Answers are grounded in this paper and cite their sources.
The dynamic equilibrium of regulated cell death (RCD) is crucial for maintaining homeostasis within the central nervous system (CNS); Dysregulation of lysine lactylation is linked to acute CNS injuries. This post-translational modification involves attaching a lactyl group to lysine residues. Enzyme-mediated lysine L-lactylation (KL-la) is the most studied form of lactylation in eukaryotes. KL-la influences gene transcription through histone lactylation and directly modulates protein function via non-histone lactylation, thereby playing a critical role in regulating various RCD subtypes. This review examines acute CNS diseases like stroke, traumatic brain injury, spinal cord injury, and hypoxic-ischemic encephalopathy, providing a detailed overview of L-lactate sources, KL-la landscape, and its links to RCD. For KL-la and RCD, site-directed mutagenesis or rescue experiments now provide causal evidence for various cell death types, such as apoptosis, pyroptosis, and others. Most evidence focuses on non-histone lactylation, with limited direct evidence for histone lactylation. The regulatory effects of KL-la vary by disease context and target protein. Validated non-histone sites are associated with mitochondrial homeostasis, indicating that mitochondrial quality control plays a key role in the regulation of various RCD subtypes by KL-la. In acute CNS diseases, L-lactate is derived mainly from astrocytes, microglia, and neurons, with no current evidence implicating oligodendrocytes. The KL-la landscape is unevenly distributed across diseases, with some studies indicating cell-type and site-specific patterns. Among the identified histone lactylation sites, H3K18La is the most frequently reported; however, its apparent prevalence may be influenced by detection biases associated with antibody accessibility. KL-la has a dual regulatory role in RCD during acute CNS diseases, with validated sites only on non-histone substrates and no direct evidence on histones. Research mainly targets neurons and the acute phase, leaving KL-la’s role in the inflammatory and repair phases largely unexplored. This review also explores the therapeutic potential of targeting lactate metabolism and lactylation in acute CNS diseases. It highlights that current strategies mainly validate specific KL-la sites’ functionality, not provide practical treatments. Future research should focus on unbiased identification and causal validation of KL-la sites and clarify D-lactylation’s role in these diseases.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: